Overview

• The order covers patented or branded medicines and exempts companies that have already begun constructing U.S. manufacturing facilities, which the White House defined as having started site work.
• The package also adds tariffs of 50% on kitchen cabinets and bath vanities, 30% on upholstered furniture, and 25% on heavy trucks made abroad, all slated to begin Oct. 1.
• The European Commission said the July–August joint declaration with Washington limits combined tariffs on EU drug exports to a maximum of 15%, creating an immediate constraint on higher U.S. levies.
• Industry groups in the U.S. and Europe warned of higher costs, supply‑chain disruptions and risks to patient access, even as major drugmakers highlight or accelerate U.S. investments such as Eli Lilly’s new plants in Houston and Virginia.
• Implementation details remain pending with the Section 232 findings on pharmaceuticals not yet published, markets showed volatility in healthcare shares, and analysts noted generics were not included though extending tariffs to them could heighten shortage risks.